European Medicines Agency Validates Application for Tepotinib ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Nov. 26, 2020 /PRNewswire-AsiaNet/-- Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) ...
Authors: LATEST ASIANET NEWS RELEASES